tiprankstipranks
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14)
SGX:T14
T14
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
RESEARCH TOOLSreports

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (T14) Share Price & Analysis

1 Followers

T14 Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.32 - $2.33
Previous Close$1.99
Volume207.50K
Average Volume (3M)138.90K
Market Cap
$3.36B
Enterprise Value$3.00B
Total Cash (Recent Filing)¥2.88B
Total Debt (Recent Filing)¥257.91M
Price to Earnings (P/E)10.6
Beta0.48
Mar 30, 2024
EPS EstimateN/A
Dividend Yield8.09%
Share Statistics
EPS (TTM)0.18
Shares Outstanding768,873,076
10 Day Avg. Volume227,780
30 Day Avg. Volume138,895
Standard Deviation0.09
R-Squared0.02
Alpha0.00437
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S News

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.03%<0.01%99.96%
0.00%
Insiders
<0.01% Other Institutional Investors
99.96% Public Companies and
Individual Investors

T14 FAQ

What was Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s price range in the past 12 months?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S lowest share price was $1.32 and its highest was $2.33 in the past 12 months.
    What is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s market cap?
    Currently, no data Available
    When is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s upcoming earnings report date?
    Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s upcoming earnings report date is Mar 30, 2024 which is 32 days ago.
      How were Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s earnings last quarter?
      Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S released its earnings results on Oct 30, 2023. The company reported $0.024 earnings per share for the quarter, beating the consensus estimate of N/A by $0.024.
        Is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S overvalued?
        According to Wall Street analysts Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S pay dividends?
          Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S pays a Semiannually dividend of $0.16 which represents an annual dividend yield of 8.09%. See more information on Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S dividends here
            What is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s EPS estimate?
            Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S have?
            Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has 200,000,000 shares outstanding.
              What happened to Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s price movement after its last earnings report?
              Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S reported an EPS of $0.024 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S?
                Currently, no hedge funds are holding shares in SG:T14
                ---

                Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Stock Smart Score

                Company Description

                Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S

                Tianjin Zhong Xin Pharmaceutical Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
                Bumitama Agri Ltd.
                Advanced Blockchain AG
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis